Clinical Trials Directory

Trials / Unknown

UnknownNCT03014557

China REgistry of WATCHMAN

China REgistry of WATCHMAN Left Atrial Appendage Closure for Non-valvular Atrial Fibrillation

Status
Unknown
Phase
Study type
Observational
Enrollment
413 (estimated)
Sponsor
Fu Wai Hospital, Beijing, China · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This registry is designed to observe the safety and effectiveness of WATCHMAN left atrial appendage closure technology in a Chinese population.

Detailed description

In this prospective, multi-center, single arm observational study, 413 patients with non-valvular atrial fibrillation intended to be implanted with a WATCHMAN device based on real clinical practice will be enrolled. Enrolled subjects will be followed up for 5 years.Primary endpoints include stroke, systematic embolism, cardiovascular death, and procedure or device related complications, etc.

Conditions

Interventions

TypeNameDescription
DEVICEleft atrial appendage closure device implantationto permanently implant a WATCHMAN left atrial appendage closure device through trans-catheter approach

Timeline

Start date
2016-11-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2017-01-09
Last updated
2017-01-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03014557. Inclusion in this directory is not an endorsement.

China REgistry of WATCHMAN (NCT03014557) · Clinical Trials Directory